A reduced dosing strategy can work for Alectinib in ALK rearranged non small cell lung cancer

被引：0
|
作者：
Sacdalan, Danielle Benedict [1 ,2 ]
Lucero, Josephine Anne [2 ]
机构：
[1] Univ Toronto, Inst Med Sci, Temerty Fac Med, Toronto, ON, Canada
[2] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
CANCER TREATMENT AND RESEARCH COMMUNICATIONS | 2022年 / 33卷
关键词：
D O I：
10.1016/j.ctarc.2022.100662
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The role of alectinib in the treatment of advanced ALK-rearranged non-small-cell lung cancer
    Srinivasamaharaj, Srividya
    Salame, Bilal Khameze
    Rios-Perez, Jorge
    Kloecker, Goetz
    Perez, Cesar A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (12) : 1227 - 1233
  • [2] Safety of alectinib for the treatment of metastatic ALK-rearranged non-small cell lung cancer
    Zhu, Viola
    Ou, S. H.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 509 - 514
  • [3] Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
    Kate McKeage
    Drugs, 2015, 75 : 75 - 82
  • [4] Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer
    Ando, Chihiro
    Ichihara, Eiki
    Nishi, Tatsuya
    Morita, Ayako
    Hara, Naofumi
    Takada, Kenji
    Nakasuka, Takamasa
    Watanabe, Hiromi
    Kano, Hirohisa
    Nishii, Kazuya
    Makimoto, Go
    Kondo, Takumi
    Ninomiya, Kiichiro
    Fujii, Masanori
    Kubo, Toshio
    Ohashi, Kadoaki
    Matsuoka, Ken-ichi
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    CANCER SCIENCE, 2023, 114 (11) : 4343 - 4354
  • [5] Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
    McKeage, Kate
    DRUGS, 2015, 75 (01) : 75 - 82
  • [6] Alectinib: a selective, next-generation ALK inhibitor for treatment of ALK-rearranged non-small-cell lung cancer
    Santarpia, Mariacarmela
    Altavilla, Giuseppe
    Rosell, Rafael
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (03) : 255 - 268
  • [7] Is alectinib the new first line therapy in ALK-rearranged advanced non-small cell lung cancer?
    van der Wekken, Anthonie J.
    Kok, Klaas
    Groen, Harry J. M.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S2130 - S2132
  • [8] Alectinib in the treatment of ocular metastases of ALK rearranged non small cell lung cancer Description of 2 case reports
    Gozzi, Elisa
    Angelini, Francesco
    Rossi, Luigi
    Leoni, Valentina
    Trenta, Patrizia
    Cimino, Giuseppe
    Tomao, Silverio
    MEDICINE, 2020, 99 (27) : E21004
  • [9] Erratum to: Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
    Kate McKeage
    Drugs, 2015, 75 : 241 - 241
  • [10] Tumor Volume Nadir in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Treated With Alectinib
    Nishino, Mizuki
    Wei, Zihan
    Mazzola, Emanuele
    Hino, Takuya
    Tseng, Shu-Chi
    Sanchez, Michelle E.
    Hatabu, Hiroto
    Johnson, Bruce E.
    Awad, Mark M.
    JCO PRECISION ONCOLOGY, 2023, 7
12345